Summer Sale

Up to 30% off — ends 7 Aug

ONLY00h00m00s

Get 30% Off

Up to 30% off — ends 7 Aug

ONLY00h00m00s

Pamela Becker

Professor of Clinical Medicine

University of California, Irvine

United States

This profile is automatically generated from trusted academic sources.

Google Scholar

ORCID

How do I reach out?

Meet Kite AI

Contact this professor

ORCID

Google Scholar

Research Interests

Immunology

40%

Internal Medicine

30%

Hematology

80%

Oncology

40%

Cancer Therapy

30%

Leukemia

30%

Graft-versus-host Disease

20%

Ask ApplyKite AI

Start chatting

How can you help me contact this professor?

What are this professor's research interests?

How should I write an email to this professor?

Articles14

Allogeneic transplantation provides added benefit to FMS‐like tyrosine kinase 3 (FLT3) inhibitors for both low‐intensity and high‐intensity regimens in FLT3‐mutated acute myeloid leukemia

Article Link

Year:

2025

VenEx precisely predicts ven-aza response

Article Link

Year:

2025

Combined Cytokine Blockade Therapy (CCBT) Using Basiliximab and Infliximab for Treatment of Steroid-Refractory Graft-Versus-Host Disease (SR-GvHD)

Article Link

Year:

2024

Phase 1/2 study of sorafenib added to cladribine, high-dose cytarabine, G-CSF, and mitoxantrone in untreated AML

Article Link

Year:

2023

Comparison between measurable residual disease relapse and morphologic relapse in acute myeloid leukemia and high-grade myeloid neoplasms

Article Link

Year:

2023

Haploidentical hematopoietic cell transplant recipient presents with late‐onset Epstein Barr virus‐associated posttransplant lymphoproliferative disorder

Article Link

Year:

2023

Potent Personalized Venetoclax Partners for Acute Myeloid Leukemia Identified by Ex Vivo Drug Screening

Article Link

Year:

2023

Physician and patient perceptions on randomization of treatment intensity for unfit adults with acute myeloid leukemia and other high-grade myeloid neoplasm

Article Link

Year:

2022

Outcomes based on treatment setting in refractory acute myeloid leukemia and other high-grade myeloid malignancies

Article Link

Year:

2022

CD19‐directed immunotherapy use in KMT2A‐rearranged acute leukemia: A case report and literature review of increased lymphoid to myeloid lineage switch

Article Link

Year:

2022

Lamin B1 deletion in myeloid neoplasms causes nuclear anomaly and altered hematopoietic stem cell function

Article Link

Year:

2022

Unsupervised discovery of dynamic cell phenotypic states from transmitted light movies

Article Link

Year:

2021

90Y-labeled anti-CD45 antibody allogeneic hematopoietic cell transplantation for high-risk multiple myeloma

Article Link

Year:

2021

A Phase Ib Study of Onvansertib, a Novel Oral PLK1 Inhibitor, in Combination Therapy for Patients with Relapsed or Refractory Acute Myeloid Leukemia

Article Link

Year:

2020

Collaborators10

Roland B. Walter

University of Washington

UNITED STATES

Tara Lin

University of Kansas Medical Center

UNITED STATES

Ryan D. Cassaday

Washington University School of Medicine

UNITED STATES

Jacob Appelbaum

Assistant Professor

University of Washington

UNITED STATES

Piyanuch Kongtim

UNITED STATES

Amer M. Zeidan

Yale University School of Medicine

UNITED STATES

Susan O’Brien

UNITED STATES

Megan Othus

Fred Hutchinson Cancer Research Center

UNITED STATES

Jian Ma

Ray and Stephanie Lane Professor of Computational Biology

Carnegie Mellon University

UNITED STATES

Lawrence Liu

Assistant Professor

Cedars-Sinai Medical Center

UNITED STATES

How do I reach out?

Meet Kite AI